We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$224M
Cap. Flow
-$309M
Cap. Flow %
-22.53%
Top 10 Hldgs %
17.96%
Holding
216
New
21
Increased
69
Reduced
53
Closed
28

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$29M
2
MXCT icon
MaxCyte
MXCT
+$14.8M
3
SKIN icon
SkinHealth Systems
SKIN
+$8.7M
4
JBTM
JBT Marel
JBTM
+$7.82M
5
EXE
Expand Energy Corp
EXE
+$7.8M

Top Sells

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$25.1M
2
INSP icon
Inspire Medical Systems
INSP
+$21.2M
3
TXG icon
10x Genomics
TXG
+$21.1M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20.2M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$13.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.81%
2 Technology 14.81%
3 Financials 9.02%
4 Industrials 8.86%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
176
10x Genomics
TXG
$6.61B
– –
-107,801
Closed -$21.1M
VICI icon
177
VICI Properties
VICI
$29.4B
– –
-287,225
Closed -$8.91M
VMEO
178
DELISTED
Vimeo
VMEO
– –
-169,972
Closed -$8.33M
ZION icon
179
Zions Bancorporation
ZION
$10.3B
– –
-79,500
Closed -$4.2M
ZLAB icon
180
Zai Lab
ZLAB
$2.62B
– –
-141,881
Closed -$25.1M
ZM icon
181
Zoom
ZM
$30.6B
– –
-2,038
Closed -$789K
OKUR
182
OnKure Therapeutics
OKUR
$168M
– –
-22,619
Closed -$2.11M
MBII
183
DELISTED
Marrone Bio Innovations, Inc.
MBII
– –
-290,528
Closed -$482K
TRIL
184
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-1,381,983
Closed -$13.4M
CMIIU
185
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
– –
-135,744
Closed -$1.83M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Nicholas Investment Partners held 216 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $309M in Q3 2021, closing 28 positions and reducing 53 holdings. Its most notable exit was Zai Lab, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Ginkgo Bioworks worth $27.6M.

  • Nicholas Investment Partners's largest Q3 2021 buy was Ginkgo Bioworks: 59,532 shares worth $27.6M.
  • Nicholas Investment Partners added most to Expand Energy Corp in Q3 2021, an estimated $7.8M increase.
  • Nicholas Investment Partners's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.2M.
  • Nicholas Investment Partners fully exited Zai Lab in Q3 2021, selling an estimated $25.1M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.37B portfolio in Q3 2021.
  • Nicholas Investment Partners opened 21 new positions and closed 28 in Q3 2021.
  • Nicholas Investment Partners's portfolio value fell 14% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.